Velsecorat clinical trials
Also written AZD7594.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How each study uses velsecorat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- AZD7594
- 4
Studies by the year they started
6 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2016 | 3 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses velsecorat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With AsthmaCompletedPhase 1AstraZenecaNCT03976869Written as AZD7594
- A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.CompletedPhase 1AstraZenecaNCT04072562Written as AZD7594
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese MenCompletedPhase 1AstraZenecaNCT02645253Written as AZD7594 inhalation powder (200 μg)
- A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male ParticipantsCompletedPhase 1AstraZenecaNCT02967159Written as AZD7594
- A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male SubjectsCompletedPhase 1AstraZenecaNCT02648438Written as AZD7594 Solution for infusion (150 μg intravenous formulation)
- To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594CompletedPhase 1AstraZenecaNCT01636024Written as AZD7594
Codes
What other systems call velsecorat · ClinicalTrials.gg INT001360
- MeSH (NLM) C000708431velsecoratOne source NLM
- UNII (FDA) P30N0911C2VELSECORATConfirmed FDA, NLM
- NCI Thesaurus C171915VelsecoratOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000708431 | velsecorat | One source NLM |
| UNII (FDA) | P30N0911C2 | VELSECORAT | Confirmed FDA, NLM |
| NCI Thesaurus | C171915 | Velsecorat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.